hereditary angioedema - Search News

Order byBest matchMost fresh

News

Hereditary Angioedema, FDA and RNA

Medpage Today on MSN · 11h

RNA-Targeted Drug Approved for Preventing Hereditary Angioedema Attacks

In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly subcutaneously. Weeks later, regulators approved sebetralstat (Ekterly) as an oral, on-demand therapy for HAE.

Continue reading

The American Journal of Managed Care · 14h

FDA Approves First RNA-Targeted Treatment for Hereditary Angioedema

FDA approves Ionis drug that prevents swelling attacks caused by a rare disease

pharmaphorum49m

Ionis brings long-acting treatment option to HAE patients

Ionis has won an FDA green light for an RNA-based hereditary angioedema (HAE) treatment, Dawnzera, that can be ...

Stocktwits on MSN5h

Retail Traders Pile Into Ionis As Wall Street Hikes Price Targets On FDA Approval Of Swelling Disorder Therapy

Wall Street analysts boosted their targets on Ionis Pharmaceuticals after the FDA approved its RNA-based drug Dawnzera for ...

Fierce Pharma13h

Ionis steps into crowded HAE market with FDA approval for Dawnzera

Since 2008, the FDA has approved 11 treatments for a rare genetic condition called hereditary angioedema (HAE), three of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results